Intensive blood pressure control does not lead to clinically meaningful differences in brain imaging biomarkers of Alzheimer’s disease on MRI, according to data from a US trial.

In fact, for one biomarker — hippocampal volume — those in the intensive BP control arm fared worse, with a statistically significant decrease at the four-year follow-up.